Launch/expiration date: April 18, 2025 - April 18, 2026

Goal Statement

This supplement will provide education on the physiology of carbohydrate digestion and absorption.

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists involved in the care of patients with gastrointestinal disease.

Planning Committee and Faculty

Brooks D. Cash, MD, FACG, AGAF, FASGE
Dan and Lillie Sterling Professor of Medicine
Chief, Gastroenterology, Hepatology, and Nutrition
UT Health Science Center at Houston
McGovern Medical School
Houston, TX

Daksesh Patel, DO
Illinois Gastroenterology Group
Chicago, Illinois

Kate Scarlata, MPH, RDN
For a Digestive Peace of Mind
Private Practice
Medway, MA

Educational Objectives

• Describe the role of intestinal disaccharidases in health and disease
• Summarize recent evidence regarding the epidemiology, presentation, and natural history of patients with CSID
• Summarize the benefits and limitations of current diagnostic tests for CSID"
• Incorporate practical screening/diagnostic strategies to identify appropriate patients for screening, interpret test results accurately, and effectively differentiate CSID from other common GI disorders seen in clinical practice
• Describe the role of dietary modification and enzyme supplementation in the management of patients with CSID

Accreditation

In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and the Gi Health Foundation (GiHF). MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Credit

Medical Education Resources designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures

Brooks D. Cash, MD
Speaker: QOL Medical, Abbvie, Salix, Alnylam, Ardelyx, Phathom
Consultant: Ardelyx, AstraZeneca, Phathom

Daksesh Patel, DO
Speaker: QOL

Kate Scarlata, RDN
Consultant: Schar, Olipop, Ardelyx
Sponsorship: Schar, QOL Medical, Biomerica, Ardelyx, Activa, Salix Pharmaceuticals, BioK

Disclosure of All Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.

MER and the Gi Health Foundation planners have no relevant financial relationships to disclose.

Disclaimer

The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources, Gi Health Foundation and/or QOL Medical. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.

MER Privacy Policy: http://cmepartner.org/privacy

Method of Participation:

There are no fees for participating in and receiving credit for this activity. During the period April 2025 - April 2026, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the posttest by recording the best answer to each question, and 4) complete the evaluation form. A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 75% or better. Please visit https://education.hcp-education.org/content/demystifying-carbohydrate-maldigestion-clinical-review complete the post-test and evaluation.

Media:
Internet, print.

Fee Information:
There is no fee for this educational activity.

Jointly provided by the Medical Education Resources and (the) Gi Health Foundation.

Supported by an educational grant from QOL Medical.